A system-based approach to depression management in primary care using the Patient Health Questionnaire-9

Mayo Clinic Proceedings

Volumn 82, Issue 11, 2007, Pages 1395-1402

  DeJesus, Ramona S ^a   Vickers, Kristin S ^a   Melin, Gabrielle J ^a   Williams, Mark D ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CITALOPRAM; CLOMIPRAMINE; DESIPRAMINE; DOPAMINE UPTAKE INHIBITOR; DOXEPIN; ESCITALOPRAM; FLUOXETINE; FLUVOXAMINE; IMIPRAMINE; MIRTAZAPINE; MOCLOBEMIDE; MONOAMINE OXIDASE INHIBITOR; NORADRENALIN UPTAKE INHIBITOR; NORTRIPTYLINE; PAROXETINE; PHENELZINE; PROTRIPTYLINE; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN RECEPTOR AFFECTING AGENT; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRANYLCYPROMINE; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT; TRIMIPRAMINE; VENLAFAXINE;

CARDIOVASCULAR DISEASE; CLINICAL PRACTICE; COGNITIVE THERAPY; CONSTIPATION; DELIRIUM; DEPRESSION; ERECTILE DYSFUNCTION; EXTRAPYRAMIDAL SYMPTOM; FOLLOW UP; HEADACHE; HEART ARRHYTHMIA; HEART OUTPUT; HUMAN; HYPERTENSION; HYPERTENSIVE CRISIS; INSOMNIA; MYOCLONUS; NAUSEA; NEUROLOGIC DISEASE; ORGASM DISORDER; ORTHOSTATIC HYPOTENSION; PATIENT EDUCATION; PATIENT HEALTH QUESTIONNAIRE; PRACTICE GUIDELINE; PRIAPISM; PRIMARY MEDICAL CARE; PSYCHOTHERAPY; QUESTIONNAIRE; RATING SCALE; RELIABILITY; REVIEW; SEDATION; SEIZURE; SEROTONIN SYNDROME; SEXUAL AROUSAL DISORDER; SEXUAL DYSFUNCTION; SIDE EFFECT; SYSTEM ANALYSIS; TARDIVE DYSKINESIA; TREATMENT RESPONSE; URINARY HESITANCY; VALIDITY; VISUAL IMPAIRMENT; VOMITING; WEIGHT GAIN; XEROSTOMIA;

EID: 35848947233     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/82.11.1395     Document Type: Review

References (31)

1. Murray CJL, Lopez AD, eds. The Global Burden of Disease: A Comprehensive Assessment of Mortality and Disability From Diseases, Injuries, and Risk Factors in 1990 and Projected to 2020. Cambridge, MA: Harvard University Press; 1996.
2. Murphy JM, Laird NM, Monson RR, Sobol AM, Leighton AH. A 40-year perspective on the prevalence of depression: the Stirling County Study. Arch Gen Psychiatry. 2000; 57(3):209-215.
3. Hankin BL. Adolescent depression: description, causes, and interventions. Epilepsy Behav. 2006 Feb;8(1):102-114. Epub 2005 Dec 13.
4. Ebmeier KP, Donaghey C, Steele JD. Recent developments and current controversies in depression. Lancet. 2006;367(9505):153-167.
5. Alexopoulos GS. Depression in the elderly. Lancet. 2005;365(9475): 1961-1970.
6. Kates N, Mach M. Chronic disease management for depression in primary care: a summary of the current literature and implications for practice. Can J Psychiatry. 2007;52(2):77-85.
7. Whooley MA, Simon GE. Managing depression in medical outpatients. N Engl J Med. 2000;343(26):1942-1950.
8. Cuijpers P, Smit F. Excess mortality in depression: a meta-analysis of community studies. J Affect Disord. 2002;72(3):227-236.
9. Kessler RC, Berglund P, Demler O, et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication NCS-R). JAMA. 2003;289(23):3095-3105.
10. Pignone MP, Gaynes BN, Rushton JL, et al. Screening for depression in adults: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2002;136(10):765-776.
11. Spitzer RL, Kroenke K, Williams JB. Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. JAMA. 1999;282 (18):1737-1744.
12. Horn EK, van Benthem TB, Hakkaart-van Roijen L, et. al. Cost-effectiveness of collaborative care for chronically ill patients with comorbid depressive disorder in the general hospital setting, a randomised controlled trial. BMC Health Serv Res. 2007;7:28.
13. Löwe B, Unützer J, Callahan CM, Perkins AJ, Kroenke K. Monitoring depression treatment outcomes with the patient health questionnaire-9. Med Care. 2004;42(12):1194-1201.
14. Huang FY, Chung H, Kroenke K, Delucchi KL, Spitzer RL. Using the Patient Health Questionnaire-9 to measure depression among racially and ethnically diverse primary care patients. J Gen Intern Med. 2006;21(6):547-552.
15. MacArthur Initiative on Depression and Primary Care. www.depression. primarycare.org. Accessed September 14, 2007.
16. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606-613.
17. Enns MW, Larsen DK, Cox BJ. Discrepancies between self and observer ratings of depression: the relationship to demographic, clinical and personality variables. J Affect Disord. 2000;60(1):33-41.
18. Corruble E, Legrand JM, Zvenigorowski H, Duret C, Guelfi JD. Concordance between self-report and clinician's assessment of depression. J Psychiatr Res. 1999;33(5):457-465.
19. Pinto-Meza A, Serrano-Blanco A, Peñarrubia, MT, Blanco E, Haro JM. Assessing depression in primary care with the PHQ-9: can it be carried out over the telephone? J Gen Intern Med. 2005;20(8):738-742.
20. Löwe B, Kroenke K, Gräfe K. Detecting and monitoring depression with a two-item questionnaire (PHQ-2). J Psychosom Res. 2005;58(2):163-171.
21. American Psychiatric Association. Practice Guideline for the Treatment of Patients With Major Depressive Disorder. 2nd ed. Arlington, VA: American Psychiatric Publishing; 2000:1-78.
22. Rush AJ, Trivedi MH, Wisniewski SR, et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry. 2006;163(11):1905-1917.
23. Vittengl JR, Clark LA, Dunn TW, Jarrett RB. Reducing relapse and recurrence in unipolar depression: a comparative meta-analysis of cognitive-behavioral therapy's effects. J Consult Clin Psychol. 2007;75(3):475-488.
24. Dimidjian S, Hollon SD, Dobson KS, et al. Randomized trial of behavioral activation, cognitive therapy, and antidepressant medication in the acute treatment of adults with major depresson. J Consult Clin Psychol. 2006; 74(4):658-670.
25. Tutty S, Ludman EJ, Simon G. Feasibility and acceptability of a telephone psychotherapy program for depressed adults treated in primary care. Gen Hosp Psychiatry. 2005;27(6):400-410.
26. Simon GE, VonKorff M, Wagner EH, Barlow W. Patterns of antidepressant use in community practice. Gen Hosp Psychiatry. 1993;15(6):339-408.
27. Löwe B, Schenkel I, Carney-Doebbeling C, Göbel C. Responsiveness of the PHQ-9 to psychopharmacological depression treatment. Psychosomatics. 2006;47(1):62-67.
28. Löwe B, Kroenke K, Herzog W, Gräfe K. Measuring depression outcome with a brief self-report instrument: sensitivity to change of the Patient Health Questionnaire (PHQ-9). J Affect Disord. 2004;81(1):61-66.
29. Gilbody S, Bower P, Fletcher J, Richards D, Sutton AJ. Collaborative care for depression: a cumulative meta-analysis and review of longer-term outcomes. Arch Intern Med. 2006;166(21):2314-2321.
30. Unützer J, Katon W, Callahan CM, et al, IMPACT Investigators. Collaborative care management of late-life depression in the primary care setting: a randomized controlled trial. JAMA. 2002;288(22):2836-2845.
31. Depression Guideline Panel. Depression in Primary Care: Treatment of Major Depression. Rockville, MD: Agency for Health Care Policy and Research; 1993. Clinical Practice Guideline No. 5, Vol 2. AJCPR publication 93-0551.